Skip to content

Opening book details…

About this Medicine article

Provisional glycoprotein IIb/IIIa blockade in a randomized investigation of bivalirudin versus heparin plus planned glycoprotein IIb/IIIa inhibition during percutaneous coronary intervention: Predictors and outcome in the Randomized Evaluation in Percutaneous coronary intervention Linking Angiomax to Reduced Clinical Events (REPLACE)–2 trial by J. Emilio Exaire; Samuel M. Butman; Ramin Ebrahimi; Neal S. Kleiman; Robert A. Harrington; Marc J. Schweiger; John A. Bittl; Kathy Wolski; Eric J. Topol; A. Michael Lincoff is a Medicine article available to read on EtoBox.

It is typically read by researchers, students, and practitioners in Medicine.

Author
J. Emilio Exaire; Samuel M. Butman; Ramin Ebrahimi; Neal S. Kleiman; Robert A. Harrington; Marc J. Schweiger; John A. Bittl; Kathy Wolski; Eric J. Topol; A. Michael Lincoff
Publisher
Elsevier Science; Elsevier ; Mosby Inc.; Elsevier BV (ISSN 1097-6744)
Published
2006
Language
EN
Field
Medicine (Health Sciences)

More by J. Emilio Exaire; Samuel M. Butman; Ramin Ebrahimi; Neal S. Kleiman; Robert A. Harrington; Marc J. Schweiger; John A. Bittl; Kathy Wolski; Eric J. Topol; A. Michael Lincoff

Browse all works by J. Emilio Exaire; Samuel M. Butman; Ramin Ebrahimi; Neal S. Kleiman; Robert A. Harrington; Marc J. Schweiger; John A. Bittl; Kathy Wolski; Eric J. Topol; A. Michael Lincoff